DE3318513C2 - - Google Patents

Info

Publication number
DE3318513C2
DE3318513C2 DE19833318513 DE3318513A DE3318513C2 DE 3318513 C2 DE3318513 C2 DE 3318513C2 DE 19833318513 DE19833318513 DE 19833318513 DE 3318513 A DE3318513 A DE 3318513A DE 3318513 C2 DE3318513 C2 DE 3318513C2
Authority
DE
Germany
Prior art keywords
lipophilic
vitamins
vitamin
hydrosols
solutions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE19833318513
Other languages
German (de)
English (en)
Other versions
DE3318513A1 (de
Inventor
Geza Takacsi Nagy
Istvan Kovats
Arpad Toth
Andrea Lazar
Geb. Pal Agnes Sors
Istvan Dr. Budapest Hu Hutas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of DE3318513A1 publication Critical patent/DE3318513A1/de
Application granted granted Critical
Publication of DE3318513C2 publication Critical patent/DE3318513C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19833318513 1982-05-21 1983-05-20 Verfahren zur herstellung von hydrophile und lipohile vitamine enthaltenden konzentrierten hydrosolen, verfahren zu deren herstellung und arzneimittel, welche diese enthalten Granted DE3318513A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU163282A HU185533B (en) 1982-05-21 1982-05-21 Process for producing concentrated hydrosoles containing h lipophilic and hydrophilic vitamines

Publications (2)

Publication Number Publication Date
DE3318513A1 DE3318513A1 (de) 1983-11-24
DE3318513C2 true DE3318513C2 (enrdf_load_stackoverflow) 1993-07-01

Family

ID=10955423

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19833318513 Granted DE3318513A1 (de) 1982-05-21 1983-05-20 Verfahren zur herstellung von hydrophile und lipohile vitamine enthaltenden konzentrierten hydrosolen, verfahren zu deren herstellung und arzneimittel, welche diese enthalten

Country Status (8)

Country Link
AT (1) AT384548B (enrdf_load_stackoverflow)
BE (1) BE896782A (enrdf_load_stackoverflow)
CA (1) CA1204385A (enrdf_load_stackoverflow)
DD (1) DD209734A5 (enrdf_load_stackoverflow)
DE (1) DE3318513A1 (enrdf_load_stackoverflow)
GB (1) GB2120939B (enrdf_load_stackoverflow)
HU (1) HU185533B (enrdf_load_stackoverflow)
SU (1) SU1220562A3 (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3053408B2 (ja) 1989-02-28 2000-06-19 日清製粉株式会社 安定化された油溶性ビタミン含有組成物
JP2822058B2 (ja) 1989-05-29 1998-11-05 ゼリア新薬工業株式会社 安定な点眼剤
DE4242876C2 (de) † 1992-12-18 1997-11-27 Beiersdorf Ag Kosmetische und/oder dermatologische Zubereitungen zur kosmetischen und/oder dermatologischen Pflege der Haut und/oder der Hautanhangsgebilde
JP2990686B2 (ja) * 1994-11-17 1999-12-13 田辺製薬株式会社 水溶性ビタミンｂ類配合総合輸液

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD36799A (enrdf_load_stackoverflow) *
DD27938A (enrdf_load_stackoverflow) *
US2417299A (en) * 1943-08-06 1947-03-11 Us Vitamin Corp Fat-soluble vitamin solutions
US2907696A (en) * 1956-01-03 1959-10-06 Pfizer & Co C Stable vitamin a for aqueous dispersions
FR1372408A (fr) * 1960-06-15 1964-09-18 Ile De Rech S Scient Et Ind So Procédé de fabrication de solutions et émulsions polyvitaminées aqueuses stablesà l'air et à la lumière
US3070499A (en) * 1960-09-19 1962-12-25 Merck & Co Inc Parenteral aqueous solutions of fat soluble vitamins
CH437995A (de) * 1963-11-01 1967-06-15 Hoffmann La Roche Verfahren zur Gewinnung von lipophile Substanzen enthaltenden Präparaten
AU2629871A (en) * 1970-03-17 1972-09-14 Merck & Co., Inc Solubilization of water and aqueous solutions in non-aqueous liquids
DE2050630A1 (de) * 1970-10-15 1972-05-31 Farbwerke Hoechst AG vormals Meister Lucius & Brüning, 6000 Frankfurt Arzneimittellösung
DE2526938C2 (de) * 1975-02-14 1982-04-22 F. Hoffmann-La Roche & Co. AG, 4002 Basel Vitaminpräparate

Also Published As

Publication number Publication date
AT384548B (de) 1987-11-25
CA1204385A (en) 1986-05-13
BE896782A (fr) 1983-09-16
HU185533B (en) 1985-02-28
SU1220562A3 (ru) 1986-03-23
GB2120939A (en) 1983-12-14
GB2120939B (en) 1986-01-22
DE3318513A1 (de) 1983-11-24
DD209734A5 (de) 1984-05-23
GB8313969D0 (en) 1983-06-29
ATA185783A (de) 1987-05-15

Similar Documents

Publication Publication Date Title
EP1993515B1 (de) Verfahren zum solubilisieren, dispergieren und stabilisieren von stoffen, nach dem verfahren hergestellte erzeugnisse sowie die verwendung derselben
DE4340781C3 (de) Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
DE69936911T2 (de) Propofolhaltiges arzneimittel enthaltend sulfite
DE3686221T2 (de) Emulsionen zur parenteralen und/oder oralen verabreichung schwer wasserloeslicher ionisierbarer hydrophober arzneistoffe.
DE3202622C2 (enrdf_load_stackoverflow)
EP1206281B1 (de) Formulierung enthaltend moxifloxacin und natriumchlorid
DE69920201T2 (de) Zusammensetzungen enthaltend glykolderivate, alkohole und vitamin d
CH693762A5 (de) Wässrige Zusammensetzungen enthaltend eine Öl-in-Wasser-Emulsion
DD298352A5 (de) Tretinoin enthaltende zubereitung und verfahren zu ihrer herstellung
EP2289539A1 (de) Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE1792410B2 (de) Arzneimittelzubereitung zur intravenösen Injektion
DE69933518T2 (de) Stabile flüssige zusammensetzungen von kalzium-ascorbat und verfahren zu ihrer herstellung und verwendung
DE19703816A1 (de) Verbesserte konzentrierte Injektions- und Infusionslösungen für die intravasale Anwendung
EP1255557B1 (de) Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung enthaltend desmopressin
DE69001991T2 (de) Fluessige arzneimittel zur nasalen anwendung, die ein polypeptid als wirksubstanz enthalten.
DE69229318T2 (de) Hydrierte Rizinusöl-enthaltende injizierbare Formulierungen mit verlängerter Wirkstoffabgabe
EP1206244B1 (de) Wässrige arzneimittelformulierung von moxifloxacin oder salzen davon
DE2601489C2 (enrdf_load_stackoverflow)
DE2323187A1 (de) Verfahren zur herstellung einer stabilisierten, pulverfoermigen secretinzubereitung durch gefriertrocknung
DE3318513C2 (enrdf_load_stackoverflow)
WO2000040236A1 (de) Taxane enthaltende stabile und sterile emulsion und verfahren zu ihrer herstellung
EP1073469B1 (de) Stabile mitoxantron-lösungen
EP0679395A1 (de) Pharmazeutische Zubereitungen aud der Basis einer Ketoprofenlösung in weichen Gelatinekapseln und Verfahren zu deren Herstellung
EP0336000B1 (de) Ambiphile Creme
EP0349797B1 (de) Stabilisierte, N-acetylcysteinhaltige Arzneimittelzubereitung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8363 Opposition against the patent
8331 Complete revocation